Array Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

ARRY 3.95 +0.08 (2.07%)
price chart
Array BioPharma Falls Despite Narrower-than-Expected Q4 Loss
Share price of Array BioPharma Inc. (ARRY - Snapshot Report) fell 5.1% after the company announced its fiscal fourth quarter results on Aug 12.
Technical Summary on Biotech Equities -- Alkermes, Amarin, Array BioPharma ...
On Friday, Array BioPharma Inc.'s stock finished the session 1.04% higher at $3.87. A total of 0.95 million shares were traded, which was below its three months average volume of 1.64 million shares.
Related articles »  
Watch List: Array BioPharma (NASDAQ:ARRY), Renren Inc. (NYSE:RENN), TC ...
On 12 AUG Array BioPharma, Inc. (NASDAQ:ARRY) announced its earnings results on Tuesday. The company reported ($0.22) earnings per share for the quarter, beating the analysts' consensus estimate of ($0.23) by $0.01.
Related articles »  
Whats Hot Today: Array BioPharma, Inc. (NASDAQ:ARRY), Marathon Oil ...
On 12 AUG Array BioPharma, Inc. (NASDAQ:ARRY) reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014.
Array BioPharma Reports Financial Results For The Fourth Quarter And Full ...
12, 2014 /PRNewswire/ -- Array BioPharma Inc. ARRY, +2.07% today reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014.
Array BioPharma (ARRY) Releases Quarterly Earnings Results, Beats ...  WKRB News
Related articles »  
Array BioPharma Falls Despite Narrower-than-Expected Q4 Loss - Analyst Blog
Key candidates in Array BioPharma's pipeline include filanesib, selumetinib and binimetinib. Array BioPharma expects Novartis, which currently owns the development and commercialization rights to binimetinib, to return the same.
Related articles »  
Watch List: Array Biopharma Inc (NASDAQ:ARRY), Quiksilver, Inc. (NYSE:ZQK ...
Las Vegas, NV - August 29, 2014 - (Tech Sonian) �Array Biopharma Inc (NASDAQ:ARRY)recently reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014.
News Recap � iStar Financial Inc. (NYSE:STAR), Array BioPharma, Inc ...
Las Vegas, NV - Aug 05, 2014� (TechSonian) �iStar Financial Inc. (STAR) announced results for the second quarter ended June 30, 2014.
Related articles »  
Small Cap Stocks in a bear Hug: Array Biopharma Inc (ARRY), Basic Energy ...
Array Biopharma Inc (NASDAQ:ARRY) reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014.
Related articles »  
Active Movers -Array Biopharma Inc (NASDAQ:ARRY),Fairchild Semiconductor ...
Las Vegas, NV - 13 August, 2014� (TechSonian) - Array Biopharma Inc (NASDAQ:ARRY) reported financial results for the fourth quarter and full year of fiscal 2014 and hold a conference call to discuss those results on Tuesday, August 12, 2014.
Array BioPharma Receives Outperform Rating from Leerink Swann (ARRY)  Watch List News (press release)
Declaration Gives New Boost to Array Biopharma (NASDAQ:ARRY), BioDelivery ...  eMarketsDaily
Related articles »